Beta Bionics, Inc. BBNX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.35M | -23.40M | -21.90M | -13.47M | -14.21M |
| Total Depreciation and Amortization | 1.31M | 1.12M | 987.00K | 935.00K | 683.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.50M | 7.15M | 5.29M | 5.24M | 4.48M |
| Change in Net Operating Assets | 4.26M | 513.00K | -8.21M | -1.34M | 317.00K |
| Cash from Operations | -12.29M | -14.62M | -23.83M | -8.63M | -8.73M |
| Capital Expenditure | -2.28M | -1.04M | -1.38M | -1.90M | -1.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -111.81M | 27.97M | 23.22M | 2.56M | 10.77M |
| Cash from Investing | -114.08M | 26.93M | 21.84M | 658.00K | 9.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 163.60M | 1.80M | 623.00K | 1.06M | 2.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 163.60M | 1.80M | 623.00K | 1.06M | 2.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.23M | 14.11M | -1.37M | -6.91M | 3.41M |